Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer

por Sagara, Y, Mimori, K, Yoshinaga, K, Tanaka, F, Nishida, K, Ohno, S, Inoue, H, Mori, M
Publicado 2004

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

por Abd El-Rehim, D M, Pinder, S E, Paish, C E, Bell, J A, Rampaul, R S, Blamey, R W, Robertson, J F R, Nicholson, R I, Ellis, I O
Publicado 2004

Real-time RT–PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer

por Benoy, I H, Elst, H, Van der Auwera, I, Laere, S Van, Dam, P van, Marck, E Van, Scharpé, S, Vermeulen, P B, Dirix, L Y
Publicado 2004

Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53

por Naumann, S C, Roos, W P, Jöst, E, Belohlavek, C, Lennerz, V, Schmidt, C W, Christmann, M, Kaina, B
Publicado 2009

Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium

por Pearce, C L, Near, A M, Van Den Berg, D J, Ramus, S J, Gentry-Maharaj, A, Menon, U, Gayther, S A, Anderson, A R, Edlund, C K, Wu, A H, Chen, X, Beesley, J, Webb, P M, Holt, S K, Chen, C, Doherty, J A, Rossing, M A, Whittemore, A S, McGuire, V, DiCioccio, R A, Goodman, M T, Lurie, G, Carney, M E, Wilkens, L R, Ness, R B, Moysich, K B, Edwards, R, Jennison, E, Kjaer, S K, Hogdall, E, Hogdall, C K, Goode, E L, Sellers, T A, Vierkant, R A, Cunningham, J C, Schildkraut, J M, Berchuck, A, Moorman, P G, Iversen, E S, Cramer, D W, Terry, K L, Vitonis, A F, Titus-Ernstoff, L, Song, H, Pharoah, P D P, Spurdle, A B, Anton-Culver, H, Ziogas, A, Brewster, W, Galitovskiy, V, Chenevix-Trench, G
Publicado 2009

A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer

por Neuhaus, T, Ko, Y, Muller, R P, Grabenbauer, G G, Hedde, J P, Schueller, H, Kocher, M, Stier, S, Fietkau, R
Publicado 2009

The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer

por Winton, E de, Heriot, A G, Ng, M, Hicks, R J, Hogg, A, Milner, A, Leong, T, Fay, M, MacKay, J, Drummond, E, Ngan, S Y
Publicado 2009

Inter-observer variability in mammography screening and effect of type and number of readers on screening outcome

por Duijm, L E M, Louwman, M W J, Groenewoud, J H, van de Poll-Franse, L V, Fracheboud, J, Coebergh, J W
Publicado 2009

Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer

por Loddo, M, Kingsbury, S R, Rashid, M, Proctor, I, Holt, C, Young, J, El-Sheikh, S, Falzon, M, Eward, K L, Prevost, T, Sainsbury, R, Stoeber, K, Williams, G H
Publicado 2009

Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study

por Kullmann, F, Hollerbach, S, Dollinger, M M, Harder, J, Fuchs, M, Messmann, H, Trojan, J, Gäbele, E, Hinke, A, Hollerbach, C, Endlicher, E
Publicado 2009

Inhibition of Akt sensitises neuroblastoma cells to gold(III) porphyrin 1a, a novel antitumour drug induced apoptosis and growth inhibition

por Li, W, Xie, Y, Sun, R W-Y, Liu, Q, Young, J, Yu, W-Y, Che, C-M, Tam, P K, Ren, Y
Publicado 2009

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II stu...

por Valle, J W, Wasan, H, Johnson, P, Jones, E, Dixon, L, Swindell, R, Baka, S, Maraveyas, A, Corrie, P, Falk, S, Gollins, S, Lofts, F, Evans, L, Meyer, T, Anthoney, A, Iveson, T, Highley, M, Osborne, R, Bridgewater, J
Publicado 2009

The impact of young age on cancer-specific and non-cancer-related survival after surgery for colorectal cancer: 10-year follow-up

por McMillan, D C, McArdle, C S
Publicado 2009

Two phase II trials of temozolomide with interferon-α2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme

por Groves, M D, Puduvalli, V K, Gilbert, M R, Levin, V A, Conrad, C A, Liu, V H, Hunter, K, Meyers, C, Hess, K R, Alfred Yung, W K
Publicado 2009

Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis

por Li, C, Gardy, R, Seon, B K, Duff, S E, Abdalla, S, Renehan, A, O'Dwyer, S T, Haboubi, N, Kumar, S
Publicado 2003

Cell adhesion to the extracellular matrix protein fibronectin modulates radiation-dependent G2 phase arrest involving integrin-linked kinase (ILK) and glycogen synthase kinase-3β (...

por Cordes, N, van Beuningen, D
Publicado 2003

Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-α in patients with progressive metastatic renal cell carcinoma

por Verra, N, Jansen, R, Groenewegen, G, Mallo, H, Kersten, M J, Bex, A, Vyth-Dreese, F A, Sein, J, van de Kasteele, W, Nooijen, W J, de Waal, M, Horenblas, S, de Gast, G C
Publicado 2003

Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience

por Schrama, J G, Holtkamp, M J, Baars, J W, Schornagel, J H, Rodenhuis, S
Publicado 2003

A case–cohort study for the disease natural history of adenoma–carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of c...

por Chen, C-D, Yen, M-F, Wang, W-M, Wong, J-M, Chen, TH-H
Publicado 2003

Intact and cleaved forms of the urokinase receptor enhance discrimination of cancer from non-malignant conditions in patients presenting with symptoms related to colorectal cancer

por Lomholt, A F, Høyer-Hansen, G, Nielsen, H J, Christensen, I J
Publicado 2009